Inmar Intelligence, a leader in technology-driven solutions, announced the divestiture of its Supply Chain Solutions division to DHL Supply Chain. This strategic move allows Inmar to prioritize its Healthcare and Martech businesses by continuing to drive innovation and deliver enhanced value to customers and consumers in these rapidly evolving markets, as well as offering an opportunity to build upon Inmar’s long-standing leadership of returns solutions through DHL. Inmar retains and continues investing in its pharmaceutical reverse distribution business, including Rx Returns and Rx Recalls.
“The divestiture sets the stage for an even deeper focus at Inmar Intelligence. That focus will be centered on executing an even more aggressive innovation pipeline on behalf of the Healthcare and Martech customers in our network,” said Spencer Baird, CEO of Inmar Intelligence. “That innovation includes upgrades across every aspect of our commercial proposition, not just new or significantly enhanced products.”
Inmar is advancing Healthcare and Martech innovation to enhance safety, access, and affordability while helping brands and retailers drive consumer engagement and achieve even stronger loyalty. Both divisions continue to leverage cutting-edge data science and artificial intelligence (AI) solutions.
Marketing Technology News: MarTech Interview with Kelly Hopping, CMO @ Demandbase
Marketing Technology News: How DAM Platforms are Evolving Today – Impact of AI in Digital Asset Management
“Inmar Intelligence and DHL share a deep commitment to customer-focused innovation,” said Spencer Baird, CEO of Inmar Intelligence. “Because of that, we are confident that DHL will build even greater things on top of the Inmar Supply Chain Solutions foundation that we developed over time.”
The integration of the Supply Chain Solutions division into DHL Supply Chain highlights the enduring value of Inmar’s reverse logistics innovations, as well as delivering a smooth transition for customers and associates, who will benefit from DHL’s global logistics expertise.
The post Inmar Intelligence Sharpens Focus on Healthcare and Martech with Strategic Divestiture first appeared on PressReleaseCC.
Inmar Intelligence Sharpens Focus on Healthcare and Martech with Strategic Divestiture first appeared on Web and IT News.
NEW YORK – Freelancers often face unique challenges during tax season. Unlike traditional employees who…
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos,…
Microsoft (US), IBM (US), SAP (Germany), Oracle (US), Salesforce (US), MicroStrategy (US), SAS Institute (US),…
Digital Identity Solutions Market by Hardware (RFID Reader & Encoder, Hardware-Based Tokens, Processor ID Cards),…
Battery Energy Storage System (BESS) Market The Battery Energy Storage System (BESS) Market is projected…
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom,…
This website uses cookies.